US EditionIn "support to Milei", the owner of Tafirol, Cicatricure and Asepxia will reinvest 50 million profits trapped in Argentina
Summary by El Cronista
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
In "support to Milei", the owner of Tafirol, Cicatricure and Asepxia will reinvest 50 million profits trapped in Argentina
The Mexican laboratory Genomma Lab, owner of brands such as Tafirol, Cicatricure and Asepxia, will reinvest $ 50 million of profits that had been trapped in Argentina due to the restrictions of the local economy.The decision was made, according to the company, to provide support to the government of Javier Milei, a day after the lifting of the exchange rate quota.Genomma, which operates in 18 countries and is present in Argentina since 2007, rep…
·Argentina
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
